Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance). AAPS J. 2017 09; 19(5):1411-1423.

View in: PubMed

subject areas

Albumins
Antineoplastic Agents
Breast Neoplasms
Dose-Response Relationship, Drug
Epothilones
Female
Humans
Models, Biological
Neoplasm Metastasis
Paclitaxel
Peripheral Nervous System Diseases

authors with profiles

Mark J. Ratain